YOUR BUSINESS AUTHORITY
Springfield, MO
Gilead Sciences Inc. has agreed to purchase German biotech firm Tubulis GmbH.
The deal is valued at up to $5 billion.
The agreement calls for $3.2 billion up front and more money if certain milestones are met.
Read more from Bloomberg.
Nixa Superintendent Gearl Loden weighs in on A-F grade cards.
SBJ announces executive newsroom hires
Thanksgiving staple recalled at Costco
HBA of Greater Springfield executive officer to retire
Timeshare exit company owner sentenced for tax evasion
Warren Buffett donates $5.5B worth of Berkshire Hathaway shares
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.